Search filters

List of works by Philipp Wolf

A bispecific diabody directed against prostate-specific membrane antigen and CD3 induces T-cell mediated lysis of prostate cancer cells

scientific article published on 20 June 2007

A new generation of monoclonal and recombinant antibodies against cell-adherent prostate specific membrane antigen for diagnostic and therapeutic targeting of prostate cancer.

scientific article published on September 2006

A recombinant PSMA-specific single-chain immunotoxin has potent and selective toxicity against prostate cancer cells.

scientific article

Androgen deprivation of prostate cancer: Leading to a therapeutic dead end

scientific article (publication date: 10 October 2015)

Anti-PSMA immunotoxin as novel treatment for prostate cancer? High and specific antitumor activity on human prostate xenograft tumors in SCID mice.

scientific article published on February 2008

Effective targeting of prostate cancer by lymphocytes redirected by a PSMA × CD3 bispecific single-chain diabody.

scientific article

Enterolactone glucuronide and β-glucuronidase in antibody directed enzyme prodrug therapy for targeted prostate cancer cell treatment.

scientific article published on 23 January 2017

High-resolution animal PET imaging of prostate cancer xenografts with three different 64Cu-labeled antibodies against native cell-adherent PSMA.

scientific article published on September 2010

Impact of Green Tea Catechin ECG and Its Synthesized Fluorinated Analogue on Prostate Cancer Cells and Stimulated Immunocompetent Cells

scientific article published on 21 February 2018

Impact of Methadone on Cisplatin Treatment of Bladder Cancer Cells.

scientific article published in March 2018

In Vitro Evaluation of Humanized/De-immunized Anti-PSMA Immunotoxins for the Treatment of Prostate Cancer

scientific article published in January 2018

In vitro and in vivo effects of a recombinant anti-PSMA immunotoxin in combination with docetaxel against prostate cancer.

scientific article

In vivo testing of 177Lu-labelled anti-PSMA antibody as a new radioimmunotherapeutic agent against prostate cancer

scientific article published on January 1, 2011

Influence of structural variations on biological activity of anti-PSMA scFv and immunotoxins targeting prostate cancer.

scientific article published on September 2010

Methadone as a "Tumor Theralgesic" against Cancer

scientific article published on 31 October 2017

Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage.

scientific article

PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen.

scientific article published on 16 March 2009

Pharmacokinetics and PET imaging properties of two recombinant anti-PSMA antibody fragments in comparison to their parental antibody.

scientific article published on 9 March 2014

Prostate extracellular vesicles in patient plasma as a liquid biopsy platform for prostate cancer using nanoscale flow cytometry

scientific article published on 22 January 2016

Pseudomonas Exotoxin A: optimized by evolution for effective killing

scientific article

Splice variant transcripts of the anterior gradient 2 gene as a marker of prostate cancer

scientific article published on September 2014

Synergistic cytotoxicity of a prostate cancer-specific immunotoxin in combination with the BH3 mimetic ABT-737.

scientific article published on 29 November 2017

Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer.

scientific article

Treatment of metastatic prostate cancer after STAMPEDE.

scientific article published on April 2017

Tumor-Specific Induction of the Intrinsic Apoptotic Pathway-A New Therapeutic Option for Advanced Prostate Cancer?

scientific article published on 02 July 2019

When monoclonal antibodies are not monospecific: Hybridomas frequently express additional functional variable regions.

scientific article published on 27 February 2018